Hepatoma Derived Growth Factor is a Nuclear Targeted Mitogen

E-ISSN： 1873-5592|4|5|367-371

ISSN： 1389-4501

Source： Current Drug Targets, Vol.4, Iss.5, 2003-07, pp. : 367-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thromboxane A 2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen

By Grosser T. Zucker T.-P. Weber A.-A. Schulte K. Sachinidis A. Vetter H. Schror K.

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma

By Escudier Bernard Albiges Laurence

Drugs, Vol. 71, Iss. 9, 2011-06 ,pp. : 1179-1191

Adis International

Access to resources Recommend Favorite

Cancer therapies targeted to the epidermal growth factor receptor and its family members

By Kane Susan E

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 147-164

Informa Healthcare

Access to resources Recommend Favorite

Growth Factor/Peptide Receptor Imaging for the Development of Targeted Therapy in Oncology

Current Pharmaceutical Design, Vol. 14, Iss. 31, 2008-11 ,pp. : 3340-3347

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C-independent activation of mitogen-activated protein kinase by epidermal growth factor in skin fibroblasts

By Le Panse R. Mitev V. Houdebine L.-M. Coulomb B.

European Journal of Pharmacology, Vol. 307, Iss. 3, 1996-07 ,pp. : 339-345

Elsevier

Access to resources Recommend Favorite